CAT-811

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameCAT-811
Drug Alias Namecalpain inhibitors (Calpain Therapeutics)macrocyclic calpain inhibitors (Lincoln University/Douglas Pharmaceuticals/University of Canterbury)calpain inhibitors (Lincoln University/Douglas Pharmaceuticals/University of Canterbury)CAT-505CAT-0059 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalpain-2 catalytic subunit inhibitorsCathepsin B inhibitors
TargetsCathepsin BCalpain-2 catalytic subunit
Therapy Area/IndicationsCataract
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandNew Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Lincoln
China Registration ClassN/A

Develop Information

Active CompaniesCalpain Therapeutics Pty Ltd
Inactive CompaniesUniversity Of LincolnUniversity Of CanterburyDouglas Pharmaceuticals Ltd
Active IndicationsCataract
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A